Coccidioidomycosis and Biologics
Susan Knowles, MD
The University of Arizona Arthritis Center
1) Discuss risk of cocci infection in patients on biologics or DMARDs
2) Review results of a retrospective chart review investigating management of immunosuppressive medications after cocci infection
3) Discuss role of cocci prophylaxis and current physician practices
Disclosure: Dr. Knowles has nothing to disclose.